
NashBio is a clinical big data, genomics, and medical imaging company that accelerates the R&D activities of partners in the biopharmaceutical, diagnostics, and AI industries. They leverage real-world clinical, genomic, and imaging data to advance the discovery and development of new therapeutics and diagnostics. As a subsidiary of Vanderbilt University Medical Center, NashBio utilizes its extensive multi-modal datasets and bioinformatics tools to support life science R&D. Their offerings are based on BioVU®, a repository of de-identified EMR and linked bio-specimen data. NashBio works with clients in pharma, biotech, diagnostics, and medical devices to address critical R&D use cases, aiming to enable better outcomes through smarter data. They also collaborate on initiatives like the Alliance for Genomic Discovery (AGD) to build large collections of genomic data linked to medical records for drug discovery.

NashBio is a clinical big data, genomics, and medical imaging company that accelerates the R&D activities of partners in the biopharmaceutical, diagnostics, and AI industries. They leverage real-world clinical, genomic, and imaging data to advance the discovery and development of new therapeutics and diagnostics. As a subsidiary of Vanderbilt University Medical Center, NashBio utilizes its extensive multi-modal datasets and bioinformatics tools to support life science R&D. Their offerings are based on BioVU®, a repository of de-identified EMR and linked bio-specimen data. NashBio works with clients in pharma, biotech, diagnostics, and medical devices to address critical R&D use cases, aiming to enable better outcomes through smarter data. They also collaborate on initiatives like the Alliance for Genomic Discovery (AGD) to build large collections of genomic data linked to medical records for drug discovery.